Top

BMC Ophthalmology

Published in:

Open Access 01-12-2015 | Research article

Association between retinal vein occlusion, axial length and vitreous chamber depth measured by optical low coherence reflectometry

Authors: Andrea Szigeti, Miklós Schneider, Mónika Ecsedy, Zoltán Zsolt Nagy, Zsuzsanna Récsán

Published in: BMC Ophthalmology | Issue 1/2015

Abstract

Background

Results of ocular biometric measurements in retinal vein occlusion (RVO) eyes are still inconclusive and controversial. The aim of this study was to evaluate the association between ocular axial length (AL), vitreous chamber depth (VCD) and both central (CRVO) and branch retinal vein occlusions (BRVO) using optical low coherence reflectometry (OLCR).

Methods

Both eyes of 37 patients with unilateral CRVO (mean age: 66 ± 14 years, male:female - 21:16) and 46 patients with unilateral BRVO (mean age: 63 ± 12 years, male:female - 24:22) were enrolled in this study. The control group consisted of randomly selected single eyes of 67 age and gender matched volunteers without the presence or history of RVO (mean age: 64 ± 14 years, male:female - 34:33). Optical biometry was performed by OLCR biometer (LenStar LS 900). Average keratometry readings, central corneal thickness (CCT), anterior chamber depth (ACD), lens thickness (LT), AL and VCD of eyes with RVO were compared with those of fellow eyes using paired t-tests and with those of control eyes using independent t-tests.

Results

Mean CCT, ACD and LT, average keratometry readings of affected RVO eyes, unaffected fellow eyes and control eyes was not statistically different in either groups. In eyes with CRVO mean AL and VCD of affected eyes were significantly shorter than those of control eyes (p < 0.001, p < 0.05), mean difference in AL and VCD between the affected and control eyes was 0.56 ± 0.15 mm and 0.45 ± 0.19 mm, respectively. In eyes with BRVO, mean AL of the affected eyes was significantly shorter with a mean difference of 0.57 ± 0.15 mm (p < 0.001) and the VCD was significantly shorter with a mean difference of 0.61 ± 0.15 mm (p < 0.001) comparing with the control eyes.

Conclusion

Shorter AL and VCD might be a potential anatomical predisposing factor for development either of CRVO or BRVO.

Browning DJ. Retinal Vein Occlusion: evidence-based management. New York: Springer Science Buisness Media; 2012. p. 1–157.CrossRef

Klein R, Moss SE, Meuer SM, Klein BE. The 15-year cumulative incidence of retinal vein occlusion: the Beaver Dam Eye Study. Arch Ophthalmol. 2008;126:513–8.CrossRefPubMed

The Eye Disease Case-control Study Group. Risk factors for branch retinal vein occlusion. Am J Ophthalmol. 1993;116:286–96.CrossRef

The Eye Disease Case-control Study Group. Risk factors for central retinal vein occlusion. Arch Ophthalmol. 1996;114:545–54.CrossRef

Hayreh SS, Zimmerman B, McCarthy MJ, Podhajsky P. Systemic diseases associated with various types of retinal vein occlusion. Am J Ophthalmol. 2001;131:61–77.CrossRefPubMed

Kolar P. Risk Factors for Central and Branch Retinal Vein Occlusion: a meta-analysis of published clinical data. J Ophthalmol. 2014, Article ID 724780, 5 pages.

Majjii AS, Janarthanan M, Naduvilath TJ. Significance of refractive status in branch retinal vein occlusion: a case control study. Retina. 1997;17:200–4.

Saxena RC, Saxena S, Rajiv N. Hyperopia in branch retinal vein occlusion. Ann Ophthalmol. 1995;27:15–8.

Ariturk N, Oge Y, Erkan D, Süllü Y, Mohajerý F. Relation between retinal vein occlusions and axial length. Br J Ophthalmol. 1996;80:633–6.CrossRefPubMedPubMedCentral

10.

Timmerman EA, de Lavalette VW, Van Den Brom HJ. Axial length as a risk factor to branch retinal vein occlusion. Retina. 1997;17:196–9.CrossRefPubMed

11.

Simons B, Brucker A. Branch retinal vein occlusion: axial length and other risk factors. Retina. 1997;17:191–5.CrossRefPubMed

12.

Bandello F, Tavola A, Pierro L, Modorati G, Azzolini C, Brancato R. Axial length and refraction in retinal vein occlusions. Ophthalmologica. 1998;212:133–5.CrossRefPubMed

13.

Kir E, Tülin Berk A, Osman Saatci A, Kaynak S, Ergin MH. Axial length and hyperopia in eyes with retinal vein occlusions. Int Ophthalmol. 1997–1998, 21: 209–11.

14.

Cekic O, Totan Y, Aydin E, Pehlivan E, Hilmioglu F. The role of axial length in central and branch retinal vein occlusion. Ophthalmic Surg Lasers. 1999;30:523–7.PubMed

15.

Tsai SC, Chen HY, Chen CY. Relationship between retinal vein occlusion and axial length. Kaohsiung J Med Sci. 2003;19:453–7.CrossRefPubMed

16.

Goldstein M, Leibovitch I, Varssano D, Rothkoff L, Feitt N, Loewensteinet A. Axial length, refractive error, and keratometry in patients with branch retinal vein occlusion. Eur J Ophthalmol. 2004;14:37–9.PubMed

17.

Mehdizadeh M, Ghassemifar V, Ashraf H, Mehryar M. Relationship between retinal vein occlusion and axial length of the eye. Asian J Ophthalmol. 2005;7:146–8.

18.

Brown MM, Brown GC, Menduke H. Central retinal vein obstruction and axial length. Ophthalmic Surg. 1990;21:623–4.PubMed

19.

Mirshahi A, Moghimi S, Rajai MT. Central retinal vein occlusion: role of axial length. Asian J Ophthalmol. 2005;7:149–51.

20.

Moghimi S, Mirshahi A, Lasheie A, Maghsoudipour M, Beheshtnejaad A. Biometric indices evaluation in central retinal vein occlusion using partial coherence laser interferometry. Eur J Ophthalmol. 2007;17:383–7.PubMed

21.

Gupta RC, Mengi RK. To study the relationship between the axial length of the eye ball and the retinal vein occlusion. J K Sc. 2010;12:180–3.

22.

Sahin A, Hamrah P. Clinically relevant biometry. Curr Opin Ophthalmol. 2012;23:47–53.CrossRefPubMedPubMedCentral

23.

Central Vein Occlusion Study Group. Baseline and early natural history report: the central vein occlusion study. Arch Ophthalmol. 1993;111:1087–95.CrossRef

24.

Agarwal A, Agarwal A, Jacob S. Phacoemulsification. 4th ed. India, New Delhi: JP Medical Ltd; 2012. p. 44–6.

25.

Read SA, Colins MJ, Alonso-Caneiro D. Validation of Optical low coherence reflectometry retinal and choroidal biometry. Optom Vis Sci. 2011;88:855–63.CrossRefPubMed

26.

Tanna H, Dubis AM, Ayub N, Tait DM, Rha J, Stepien KE. Retinal imaging using commercial broadband optical coherence tomography. Br J Ophthalmol. 2010;94:372–6.CrossRefPubMed

27.

Bjeloš RM, Bušić M, Cima I, Kuzmanović EB, Bosnar D, Miletić D. Comparison of optical low-coherence reflectometry and applanation ultrasound biometry on intraocular lens power calculation. Graefes Arch Clin Exp Ophthalmol. 2011;249:69–75.CrossRef

28.

Salouti R, Nowroozzadeh MH, Zamani M, Ghoreyshi M, Salouti R. Comparison of the ultrasonographic method with 2 partial coherence interferometry methods for intraocular lens power calculation. Optometry. 2011;82:140–7.CrossRefPubMed

29.

Ueda T, Nawa Y, Hara Y. Relationship between the retinal thickness of the macula and the difference in axial length. Graefes Arch Clin Exp Ophthalmol. 2006;244:498–501.CrossRefPubMed

30.

Attas-Fox L, Zadok D, Gerber Y, Morad Y, Eting E, Benamou N, et al. Axial length measurement in eyes with diabetic macular edema: a-scan ultrasound versus IOLMaster. Ophthalmology. 2007;114:1499–504.CrossRefPubMed

31.

Rajan MS, Bunce C, Tuft S. Interocular axial length difference and age-related cataract. J Cataract Refract Surg. 2008;34:76–9.CrossRefPubMed

32.

Jabbour J, Irwig L, Macaskill P, Hennessy MP. Intraocular lens power in bilateral cataract surgery: whether adjusting for error of predicted refraction in the first eye improves prediction in the second eye. J Cataract Refract Surg. 2006;32:2091–7.CrossRefPubMed

33.

McIntosh RL, Rogers SL, Lim L, Cheung N, Wang JJ, Mitchell P, et al. Natural history of central retinal vein occlusion: an evidence-based systematic review. Ophthalmology. 2010;117:1113–23.CrossRefPubMed

34.

Rogers SL, McIntosh RL, Lim L, Mitchell P, Cheung N, Kowalski JW, et al. Natural history of branch retinal vein occlusion: an evidence-based systematic review. Ophthalmology. 2010;117:1094–101.CrossRefPubMed

35.

Green WR, Chan CC, Hutchins GM, Terry JM. Central retinal vein occlusion: a prospective histopathologic study of 29 eyes in 28 cases. Retina. 1981;1:27–55.PubMed

36.

Frangieh GT, Green WR, Barraquer-Somers E, Finkelstein D. Histopathologic study of nine branch retinal vein occlusions. Arch Ophthalmol. 1982;100:1132–40.CrossRefPubMed

37.

Ren R, Wang N, Li B, Li L, Gao F, Xu X, et al. Lamina cribrosa and peripapillary sclera histomorphometry in normal and advanced glaucomatous Chinese eyes with various axial length. Invest Ophthalmol Vis Sci. 2009;50:2175–84.CrossRefPubMed

38.

Oliveira C, Harizman N, Girkin CA, Xie A, Tello C, Liebmannet JM, et al. Axial length and optic disc size in normal eyes. Br J Ophthalmol. 2007;91:37–9.CrossRefPubMed

Title: Association between retinal vein occlusion, axial length and vitreous chamber depth measured by optical low coherence reflectometry
Authors: Andrea Szigeti
Miklós Schneider
Mónika Ecsedy
Zoltán Zsolt Nagy
Zsuzsanna Récsán
Publication date: 01-12-2015
Publisher: BioMed Central
Published in: BMC Ophthalmology / Issue 1/2015
Electronic ISSN: 1471-2415
DOI: https://doi.org/10.1186/s12886-015-0031-1

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Association between retinal vein occlusion, axial length and vitreous chamber depth measured by optical low coherence reflectometry

Abstract

Background

Methods

Results

Conclusion

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Background

Methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 1/2015

Bilateral cystoid macular edema following docetaxel chemotherapy in a patient with retinitis pigmentosa: a case report

23 Gauge pars plana vitrectomy for the removal of retained intraocular foreign bodies

Intravitreal ranibizumab monotherapy to treat retinopathy of prematurity zone II, stage 3 with plus disease

Ranibizumab for macular edema secondary to retinal vein occlusion: a meta-analysis of dose effects and comparison with no anti-VEGF treatment

Prospective, randomized, double-blind trial to investigate the efficacy and safety of corneal cross-linking to halt the progression of keratoconus

Association between a vascular endothelial growth factor gene polymorphism (rs2146323) and diabetic retinopathy: a meta-analysis